Claudio A. Benadiva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Claudio A. Benadiva has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
J.C. Nulsen
21 shared publicationsL. Engmann
15 shared publicationsD.B. Maier
12 shared publicationsL.L. Engmann
11 shared publicationsJ. Nulsen
10 shared publicationsLawrence Engmann
The Center for Advanced Reproductive Services, Division of Reproductive Endocrinology and Infertility, University of Connecticut School of Medicine, Farmington, Connecticut
10 shared publications
Latest Publications
- Open Access
- 15 November 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (22)
Defects in meiosis I contribute to the genesis of androgenetic hydatidiform moles
To identify novel genes responsible for recurrent hydatidiform moles (HMs), we performed exome sequencing on 75 unrelated patients who were negative for mutations in the known genes. We identified biallelic deleterious variants in 6 genes, FOXL2 , MAJIN , KASH5 , SYCP2 , MEIOB , and HFM1 , in patients with androgenetic HMs, including a familial case of 3 affected members. Five of these genes are essential for meiosis I, and their deficiencies lead to premature ovarian insufficiency. Advanced maternal age is the strongest risk factor for sporadic androgenetic HM, which affects 1 in every 600 pregnancies. We studied Hfm1 –/– female mice and found that these mice lost all their oocytes before puberty but retained some at younger ages. Oocytes from Hfm1 –/– mice initiated meiotic maturation and extruded the first polar bodies in culture; however, their meiotic spindles were often positioned parallel, instead of perpendicular, to the ooplasmic membrane at telophase I, and some oocytes extruded the entire spindle with all the chromosomes into the polar bodies at metaphase II, a mechanism we previously reported in Mei1 –/– oocytes. The occurrence of a common mechanism in two mouse models argues in favor of its plausibility at the origin of androgenetic HM formation in humans.
- 15 November 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (22)
Open AccessDefects in meiosis I contribute to the genesis of androgenetic hydatidiform moles
To identify novel genes responsible for recurrent hydatidiform moles (HMs), we performed exome sequencing on 75 unrelated patients who were negative for mutations in the known genes. We identified biallelic deleterious variants in 6 genes, FOXL2 , MAJIN , KASH5 , SYCP2 , MEIOB , and HFM1 , in patients with androgenetic HMs, including a familial case of 3 affected members. Five of these genes are essential for meiosis I, and their deficiencies lead to premature ovarian insufficiency. Advanced maternal age is the strongest risk factor for sporadic androgenetic HM, which affects 1 in every 600 pregnancies. We studied Hfm1 –/– female mice and found that these mice lost all their oocytes before puberty but retained some at younger ages. Oocytes from Hfm1 –/– mice initiated meiotic maturation and extruded the first polar bodies in culture; however, their meiotic spindles were often positioned parallel, instead of perpendicular, to the ooplasmic membrane at telophase I, and some oocytes extruded the entire spindle with all the chromosomes into the polar bodies at metaphase II, a mechanism we previously reported in Mei1 –/– oocytes. The occurrence of a common mechanism in two mouse models argues in favor of its plausibility at the origin of androgenetic HM formation in humans.
- Open Access
- 18 April 2024
- Published by Edorium Journals Pvt. Ltd. in Journal of Case Reports and Images in Obstetrics and Gynecology
- Vol. 10 (1) , 23-28
Primary omental ectopic pregnancy after frozen-thawed single embryo transfer: A case report and review of the literature
Introduction: The objective of this case report is to present the first known case of a primary omental ectopic pregnancy following frozen-thawed embryo transfer. Case Report: A 35-year-old G0 female with severe male factor infertility underwent a frozen-thawed single embryo transfer. Serial transvaginal ultrasounds and beta human chorionic gonadotropin levels led to the diagnosis of ectopic pregnancy. The patient did not respond to medical management with methotrexate. On laparoscopy, an ectopic pregnancy was diagnosed on the greater omentum. The pregnancy was resected with the LigaSure device. Pathology evaluation was consistent with an omental ectopic pregnancy. Conclusion: Although rare, omental ectopic pregnancy should remain in the differential in the setting of a pregnancy of unknown location.
- 18 April 2024
- Published by Edorium Journals Pvt. Ltd. in Journal of Case Reports and Images in Obstetrics and Gynecology
- Vol. 10 (1) , 23-28
Open AccessPrimary omental ectopic pregnancy after frozen-thawed single embryo transfer: A case report and review of the literature
Introduction: The objective of this case report is to present the first known case of a primary omental ectopic pregnancy following frozen-thawed embryo transfer. Case Report: A 35-year-old G0 female with severe male factor infertility underwent a frozen-thawed single embryo transfer. Serial transvaginal ultrasounds and beta human chorionic gonadotropin levels led to the diagnosis of ectopic pregnancy. The patient did not respond to medical management with methotrexate. On laparoscopy, an ectopic pregnancy was diagnosed on the greater omentum. The pregnancy was resected with the LigaSure device. Pathology evaluation was consistent with an omental ectopic pregnancy. Conclusion: Although rare, omental ectopic pregnancy should remain in the differential in the setting of a pregnancy of unknown location.
- 6 October 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 120 (4) , e305
IN LETROZOLE-STIMULATED FET CYCLES, HOW WORRIED SHOULD WE BE ABOUT A LOW ESTRADIOL LEVEL?
- 6 October 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 120 (4) , e305
IN LETROZOLE-STIMULATED FET CYCLES, HOW WORRIED SHOULD WE BE ABOUT A LOW ESTRADIOL LEVEL?
- Open Access
- 24 May 2023
- Published by Elsevier in F&S Reports
- Vol. 4 (3) , 245-250
Macroprolactinemia: a mini-review and update on clinical practice
- 24 May 2023
- Published by Elsevier in F&S Reports
- Vol. 4 (3) , 245-250
Open AccessMacroprolactinemia: a mini-review and update on clinical practice
- Open Access
- 1 December 2020
- Published by Elsevier in F&S Reports
- Vol. 1 (3) , 249-256
In vitro fertilization outcomes after preimplantation genetic testing for chromosomal structural rearrangements comparing fluorescence in-situ hybridization, microarray comparative genomic hybridization, and next-generation sequencing
- 1 December 2020
- Published by Elsevier in F&S Reports
- Vol. 1 (3) , 249-256
Open AccessIn vitro fertilization outcomes after preimplantation genetic testing for chromosomal structural rearrangements comparing fluorescence in-situ hybridization, microarray comparative genomic hybridization, and next-generation sequencing
- 1 September 2019
- Published by Elsevier in Fertility and Sterility
- Vol. 112 (3) , e227-E227
Impact of preimplantation genetic testing for aneuploidy (PGT-A) on gestational carrier (GC) cycles in the United States
- 1 September 2019
- Published by Elsevier in Fertility and Sterility
- Vol. 112 (3) , e227-E227
Impact of preimplantation genetic testing for aneuploidy (PGT-A) on gestational carrier (GC) cycles in the United States
- 1 May 2018
- Published by Elsevier in Fertility and Sterility
- Vol. 109 (5) , 763-767
Luteal phase support after gonadotropin-releasing hormone agonist triggering: does it still matter?
- 1 May 2018
- Published by Elsevier in Fertility and Sterility
- Vol. 109 (5) , 763-767
Luteal phase support after gonadotropin-releasing hormone agonist triggering: does it still matter?
- 3 January 2018
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 35 (4) , 669-675
Frozen blastocyst transfer outcomes in immediate versus delayed subsequent cycles following GnRH agonist or hCG triggers
The aim of this study is to analyze clinical pregnancy rates (CPR) and ongoing pregnancy rates (OPR) for frozen embryo transfers (FET) performed with blastocysts in the cycle immediately after GnRH agonist (GnRHa) versus human chorionic gonadotropin (hCG) triggers, with outcomes of delayed FET for comparison.
- 3 January 2018
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 35 (4) , 669-675
Frozen blastocyst transfer outcomes in immediate versus delayed subsequent cycles following GnRH agonist or hCG triggers
The aim of this study is to analyze clinical pregnancy rates (CPR) and ongoing pregnancy rates (OPR) for frozen embryo transfers (FET) performed with blastocysts in the cycle immediately after GnRH agonist (GnRHa) versus human chorionic gonadotropin (hCG) triggers, with outcomes of delayed FET for comparison.
- Open Access
- 1 December 2017
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 8, 18-24
The dual trigger study: Rationale and study design of a prospective double-blind randomized clinical trial comparing pregnancy rates after co-administration of low dose hCG at the time of GnRH agonist trigger or 35 h later for the prevention of OHSS
- 1 December 2017
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 8, 18-24
Open AccessThe dual trigger study: Rationale and study design of a prospective double-blind randomized clinical trial comparing pregnancy rates after co-administration of low dose hCG at the time of GnRH agonist trigger or 35 h later for the prevention of OHSS
- 1 September 2017
- Published by Elsevier in Fertility and Sterility
- Vol. 108 (3) , e343-e344
Impact of trigger medication on aneuploidy rates
- 1 September 2017
- Published by Elsevier in Fertility and Sterility
- Vol. 108 (3) , e343-e344
Impact of trigger medication on aneuploidy rates